Search for: "Roche Laboratories, Inc." Results 81 - 100 of 139
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jul 2010, 10:41 pm by Tom
Roche Laboratories is already producing and marketing a new test called the “AmpliChip CYP450”. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
21 Oct 2009, 6:13 am
(Afro-IP) 200,000 die annually because of fake malaria medicine – Smithsonian article ‘The Fatal Consequences of Counterfeit Drugs’ (Innovationpartners) ‘Translational medicine’ (IPKat) Brazil: Brazilian Ministry of Health calls for partnerships between public laboratories and private companies (IP tango) Brazil: Rio 2016 – who will pay and how? [read post]
21 Oct 2009, 5:13 am
(Afro-IP) 200,000 die annually because of fake malaria medicine - Smithsonian article 'The Fatal Consequences of Counterfeit Drugs' (Innovationpartners) 'Translational medicine' (IPKat) Brazil: Brazilian Ministry of Health calls for partnerships between public laboratories and private companies (IP tango) Brazil: Rio 2016 - who will pay and how? [read post]
21 Oct 2009, 5:13 am
(Afro-IP) 200,000 die annually because of fake malaria medicine - Smithsonian article 'The Fatal Consequences of Counterfeit Drugs' (Innovationpartners) 'Translational medicine' (IPKat) Brazil: Brazilian Ministry of Health calls for partnerships between public laboratories and private companies (IP tango) Brazil: Rio 2016 - who will pay and how? [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US: Caraco… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
7 Jun 2011, 12:42 pm
Metabolite Laboratories, Inc., 548 U. [read post]
2 Oct 2008, 12:36 pm
Danek Medical, Inc., 1999 WL 1054864, *6 (M.D. [read post]